IRF Admission denied as experimental or investigational by UnitedHealthcare?

UnitedHealthcare's specific coverage criteria for irf admission are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why UnitedHealthcare Denied IRF Admission as "Experimental" — and Why That Label Is Wrong

Labeling an Inpatient Rehabilitation Facility (IRF) admission as "experimental" or "investigational" is an unusual and legally vulnerable denial basis. IRF-level inpatient rehabilitation is an established, CMS-certified, and broadly covered level of post-acute care. It is not experimental by any recognized clinical or regulatory definition. This type of denial is most likely the result of a coding error, a miscategorized claim, or a reviewer applying the wrong clinical policy. It is highly appealable.

## Federal Appeal Rights

Experimental/investigational denials are adverse benefit determinations subject to the full federal appeal framework. Under ACA §2719, you are entitled to an internal appeal followed by an independent external review by a certified IRO with expertise in rehabilitation medicine. Under ERISA §503, employer plan members have the right to a full-and-fair review with access to the specific criteria used. The external review window is generally 4 months from the final internal denial. Expedited review is available if the patient is acutely hospitalized and discharge is imminent.

## Concrete Appeal Steps

1. Obtain the full denial letter and identify the specific UHC coverage policy cited as the basis for the experimental denial. 2. Request UHC's written clinical criteria — under ERISA §503 you are entitled to the exact criteria and any clinical guidelines the reviewer applied. 3. Document that IRF is CMS-certified and covered under Medicare and by UHC's own published policies for appropriate indications. 4. File the internal appeal. If the experimental label is upheld internally, proceed to external review immediately — this basis rarely survives independent review for an established care setting.

## Documentation to Gather

• IRF facility credentials: The facility's CMS certification documentation and, if applicable, Joint Commission accreditation. This establishes that IRF is a recognized, regulated level of care.
• Admitting physician certification and clinical notes: Documenting the rehabilitation diagnosis, the patient's functional deficits, and the clinical rationale for IRF-level care.
• Relevant CMS and specialty-society guidance: A reference (by organization name, not specific numbers) to CMS IRF coverage criteria and, where applicable, guidance from the American Academy of Physical Medicine and Rehabilitation or similar bodies, establishing that IRF is standard of care for the patient's condition.
• Functional assessments: Therapy evaluations from physical, occupational, and/or speech therapists documenting the intensity of rehabilitation need.

## Criteria-Mapping Structure

For each requirement in UHC's IRF policy, document the corresponding chart fact. Separately, address the experimental designation directly: state that IRF is CMS-certified, has decades of published outcomes data, and is covered under UHC's own published medical policy for appropriate diagnoses — then list the patient's diagnosis and show it matches an approved indication. External reviewers have strong grounds to overturn experimental denials for care settings that are regulated and reimbursed by CMS.